Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Francis Seguy"'
Autor:
Justin M. Watts, Anthony M. Hunter, Alessandra Iurlo, Blanca Xicoy, Francesca Palandri, Brandi Reeves, Alessandro Vannucchi, Prithviraj Bose, Rosa Ayala Diaz, Anna B. Halpern, Xuejun Chen, Francis Seguy, Feng Zhou, Fred Zheng, Pankit Vachhani
Publikováno v:
HemaSphere, Vol 7, p e1792906 (2023)
Externí odkaz:
https://doaj.org/article/701a01ff7dea43e6b160800d08dc06e1
Autor:
Prithviraj Bose, Sanjay Mohan, Stephen Oh, Jason Gotlib, Ellen Ritchie, Taizo Shimomura, Haris Ali, Francoise Boyer, Paola Guglielmelli, Anthony M. Hunter, Betty Lamothe, Yi Cui, Francis Seguy, Amanda Mcbride, Francesca Palandri, Masahiro Takeuchi, Jean-Jacques Kiladjian
Publikováno v:
HemaSphere, Vol 7, p e41693dd (2023)
Externí odkaz:
https://doaj.org/article/b96b25916b174c2e9c3fa889b4d0c091
Autor:
Justin Watts, Anthony M. Hunter, Alessandra Iurlo, Blanca Xicoy, Francesca Palandri, Brandi Reeves, Alessandro M. Vannucchi, Xuejun Chen, Francis Seguy, Feng Zhou, Fred Zheng, Pankit Vachhani
Publikováno v:
Blood. 140:9696-9697
Autor:
Sanjay R Mohan, Stephen T Oh, Haris Ali, Anthony M. Hunter, Francesca Palandri, Betty Lamothe, Yi Cui, Francis Seguy, Amanda McBride, Michael Robert Savona, Jean-Jacques Kiladjian, Srdan Verstovsek
Publikováno v:
Blood. 140:3943-3944
Autor:
Yan-ou Yang, Hong Yang, Betty Lamothe, Matthew Stubbs, Amanda McBride, Francis Seguy, Kevin Rockich, Jay Getsy, Phillip Wang, Xiang Liu, Jeff Jackson, Ekaterine Asatiani, Xuejun Chen
Publikováno v:
Cancer Research. 83:CT243-CT243
Disease-associated anemia is reported in over one-third of patients at MF diagnosis and can be exacerbated by currently available MF therapies. Further, anemia is associated with poor prognosis in MF. Activation of activin receptor-like kinase (ALK)-
Autor:
Francis Seguy, Christophe Bonnet, Oliver Manzke, Di Li, Björn E. Wahlin, Shankara Paneesha, Marek Trneny, K. Hübel, Stefano Luminari, Laurie H. Sehn, Ajay K. Gopal, C. W. Scholz, Antonio Salar
Publikováno v:
Hematological Oncology. 39
Autor:
Laurie H. Sehn, Christian W. Scholz, Stefano Luminari, Antonio Salar, Björn E. Wahlin, Ajay K. Gopal, Christophe Bonnet, Marek Trneny, Shankara Paneesha, Oliver Manzke, Francis Seguy, Di Li, Kai Hübel
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 21:S246
Autor:
Francis Seguy, Jean-Jacques Kiladjian, Feng Zhou, Haris Ali, Ekatherine Asatiani, Jason Gotlib, Sanjay R. Mohan, Srdan Verstovsek, Francesca Palandri, Stephen T. Oh
Publikováno v:
Cancer Research. 81:CT216-CT216
Background: Anemia represents a therapeutic challenge in patients with myelofibrosis (MF). ALK2 activation is associated with elevated hepcidin, which may contribute to anemia of chronic disease and anemia due to hematologic malignancies, and is asso
Autor:
Di Li, Shankara Paneesha, Björn E. Wahlin, Kai Hübel, Oliver Manzke, Stefano Luminari, Ajay K. Gopal, Francis Seguy, Christophe Bonnet, Christian W. Scholz, Antonio Salar, Laurie H. Sehn
Publikováno v:
Journal of Clinical Oncology. 39:TPS7568-TPS7568
TPS7568 Background: Most patients with the indolent non-Hodgkin lymphoma (NHL) subtypes FL or MZL respond to first-line treatment but relapse is common, and there is no single standard treatment for patients with R/R FL or MZL. Tafasitamab is an Fc-e
Autor:
Stephen T. Oh, Francis Seguy, Sanjay R. Mohan, Srdan Verstovsek, Haris Ali, Feng Zhou, Ekatherine Asatiani, Jason Gotlib
Publikováno v:
Blood. 136:3-3
Background: Anemia represents a challenge in the management of patients with myelofibrosis (MF); at least a third of patients with MF are reported to have hemoglobin levels Methods: INCB 00928-104 (NCT04455841) is a phase 1/2, open-label, multicenter